Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Paul Hasserjian, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Robert Hasserjian and Timothy Graubert.
Robert Hasserjian
Connection Strength
0.565
Timothy Graubert
  1. Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia. Blood. 2020 05 14; 135(20):1729-1738.
    View in: PubMed
    Score: 0.233
  2. Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly. N Engl J Med. 2016 12 08; 375(23):2273-2282.
    View in: PubMed
    Score: 0.183
  3. A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia. Cancer. 2020 03 15; 126(6):1264-1273.
    View in: PubMed
    Score: 0.057
  4. High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. Blood. 2018 06 21; 131(25):2816-2825.
    View in: PubMed
    Score: 0.050
  5. Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. J Mol Diagn. 2015 Nov; 17(6):661-8.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.